Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive gastric cancer: a dose-expansion, phase 1 study
Published Online: 2019-06-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Haeseong Park•Hiroji Iwata•Javad Shahidi•Junji Tsurutani•Kaku Saito•Kenji Tamura•Kensei Yamaguchi•Kohei Shitara•Masahiro Sugihara•Satoru Iwasa•Shanu Modi•Shigenori Kadowaki•Shunji Takahashi•Toshihiko Doi•Yoshihiko Fujisaki
